Technocrats Plasma Systems sells and integrates metal-cutting and welding equipment: plasma and now laser cutting machines, welding power sources, CNC systems, customised automation cells and robotic welding lines, plus the turnkey fabrication work, retrofits and maintenance contracts that attach to the installed base. The pre-listing research established a company whose revenue grew from ₹60,623 thousand in FY2024 to ₹1,313,090 thousand in FY2026, almost entirely through large composite turnkey contracts executed at customer sites with subcontracted fabrication, and whose operating cash flow was negative ₹50,484 thousand and ₹116,640 thousand in FY2025 and FY2026 respectively as work-in-progress and receivables absorbed the growth.
The Q2 FY27 call, the first after listing, changes the shape of the story in three ways. First, the company now has reported scale with a disclosed order book: H1 FY27 revenue from operations was ₹10,355.1 lakh, up 97.4% year on year, EBITDA ₹1,703.9 lakh at a 16.5% margin and PAT ₹1,194.8 lakh at an 11.5% margin, with an order book of about ₹60 crore executable in H2 FY27 and capacity utilisation of approximately 75% across 95 customers. Second, management has given its first explicit growth guide: approximately 45-50% revenue growth in FY27 over FY26, described as the minimum it is sure of, which implies full-year revenue near ₹190-197 crore against ₹131.31 crore in FY26. Third, and most important for the economics, management has quantified the margin difference between the two ways it executes work: outside site jobs carry 15-20% profit margins while work done in its own factory carries 40-50%, and factory sales collect immediately against advances and milestones rather than after four to five months.
That difference is the operating-leverage mechanism. The company has rented 20,000 square feet, five times the 4,000 square feet it intends to surrender, and commercial production there begins in December 2026. If site-executed work moves indoors, reported revenue need not grow faster for earnings to improve: management states that even at similar turnover, earnings will be higher because the mix shifts toward customised, high-end products built in-house. The same shift is meant to repair the working capital cycle, which management describes as about 60 days for factory work against 90-120 days for project sites, with 80-90% of sales against advance or milestone payments expected over two to three years. The funding for this came from the completed IPO, which raised approximately ₹60.98 crore; about ₹21.2 lakh had gone to capital expenditure and ₹14.74 crore to working capital as of the call, leaving about ₹34 crore undeployed, and debt to equity stood at 0.13x with ₹62.9 lakh of cash.
The optionality sits in two government-linked technology programmes. RRCAT has transferred indigenous fibre laser technology that the company intends to use for niche defence applications rather than competing with imported cutting lasers; design detailing is complete, a PhD engineer leads it, and engineering work started the month after the call, with management expecting the business only after about two years. The BARC plasma gasification programme targets export markets such as e-waste, municipal solid waste and coal gasification, where management expects a first sample order of ₹5-6 crore within FY27 and larger orders once the sample is proven, and where it claims margins well above 40-45% EBITDA without having supplied anything yet. Robotics is the third thread: a robot is installed at Swann Defense in Gujarat and a tie-up with a Chinese partner supplies collaborative robots aimed at shipbuilding, where yards are described as full for five to six years.
Capital allocation is simple and largely predetermined: IPO proceeds into plant, machinery and working capital. The near-term question is whether the plant and machinery object is actually spent and the rented facility actually starts in December 2026, since only a small fraction of the capital expenditure object had been utilised at the time of the call.
The earnings path over the next two to three years depends on three measurable things: honouring the FY27 growth floor of 45-50% while H1 already ran at 97.4%; lifting EBITDA margin from the 16.5% reported in H1 FY27 back toward the 20% seen in FY2026 as in-house mix rises; and converting the working capital cycle to roughly 60 days with advance or milestone receipts. Management's own language supports the direction but not the pace, since it puts the working capital normalisation two to three years out.
The falsifiers are specific. A FY27 outcome below the stated 45-50% floor would show that the second half failed to hold the first-half run-rate, particularly if the ₹60 crore order book executed without replacement orders. An EBITDA margin that stays near 16.5% after the December 2026 facility starts would show that the 40-50% in-house margin claim does not translate into reported profitability, most likely because site work is not transferring indoors as described. Trade receivables and inventory continuing to grow faster than revenue, with operating cash flow still negative, would show that the factory model is not shortening the cycle. And a plant and machinery spend that remains undeployed through Fiscal 2027 would leave the capacity story as paper. The gasification and defence programmes are upside rather than thesis; they should not be credited in earnings until an order is booked.
Analyst inference, stated plainly: the reported H1 FY27 result is a growth quarter with compressing margin and cash outflow, and the investment case depends on an operating-mix change that begins to bite from December 2026. That is a thesis about the next two to three years, not about the last one.
companyname: Technocrats Plasma Systems Limited ticker: TECHNOCRAT sector: Machine Tools – Metal-Cutting and Welding Equipment Manufacturing (Capital Goods) documenttype: IPO Research Report "The Issue comprises of Fresh Issue of up to 46,20,000 equity shares of our company at an issue price of ₹ [●] per equity share aggregating up to ₹ [●]." - Capital Structure, Objects of the Issue This is a 100% fresh issue. There is no offer for sale and no selling shareholder. This is growth capital, no...
Read the full report →Management explicitly guides to approximately 45-50% revenue growth in FY27 over FY26, describing it as the minimum growth it is sure of, with anything above that treated as additional. It states that growth will continue thereafter and refers to a minimum of 35-40% growth on product mix, though the same answer also mentions 40-45% and 40-60% and is contradictory. It expects a first plasma gasification order of ₹5-6 crore within FY27, export only, with larger orders once the sample is proven. It expects defence laser business to begin after about two years. It expects the mix of factory-based execution to rise, with 80-90% of sales against advance or milestone payments, over two to three years, shortening the working capital cycle to about 60 days.
Get valuation models, detailed research reports, thematic primers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Technocrats Plasma Systems and 4,900+ companies.
5-day free pass. No card required.